The Justice Department has reclassified medical marijuana from a Schedule I drug, like heroine, to a Schedule II drug, like ketamine and testosterone. President Trump called for this change to make it easier to conduct medical research on the benefits, risks, and future treatments of medical marijuana. This video explains what the reclassification does and does not mean for medical marijuana users.